263 related articles for article (PubMed ID: 33921111)
1. Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline Ovarian Tumors by Integrative Polygenic Analytics.
Chang CM; Li YF; Lin HC; Lu KH; Lin TW; Liu LC; Su KM; Chang CC
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921111
[TBL] [Abstract][Full Text] [Related]
2. Gene set-based analysis of mucinous ovarian carcinoma.
Chang CM; Wang PH; Horng HC
Taiwan J Obstet Gynecol; 2017 Apr; 56(2):210-216. PubMed ID: 28420510
[TBL] [Abstract][Full Text] [Related]
3. Synergistic AHR Binding Pathway with EMT Effects on Serous Ovarian Tumors Recognized by Multidisciplinary Integrated Analysis.
Su KM; Gao HW; Chang CM; Lu KH; Yu MH; Lin YH; Liu LC; Chang CC; Li YF; Chang CC
Biomedicines; 2021 Jul; 9(8):. PubMed ID: 34440070
[TBL] [Abstract][Full Text] [Related]
4. Gene Set-Based Integrative Analysis Revealing Two Distinct Functional Regulation Patterns in Four Common Subtypes of Epithelial Ovarian Cancer.
Chang CM; Chuang CM; Wang ML; Yang YP; Chuang JH; Yang MJ; Yen MS; Chiou SH; Chang CC
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527159
[TBL] [Abstract][Full Text] [Related]
5. Gene Set-Based Functionome Analysis of Pathogenesis in Epithelial Ovarian Serous Carcinoma and the Molecular Features in Different FIGO Stages.
Chang CM; Chuang CM; Wang ML; Yang MJ; Chang CC; Yen MS; Chiou SH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275818
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated immunological and metabolic functions discovered by a polygenic integrative analysis for PCOS.
Ho CH; Chang CM; Li HY; Shen HY; Lieu FK; Wang PS
Reprod Biomed Online; 2020 Jan; 40(1):160-167. PubMed ID: 31780352
[TBL] [Abstract][Full Text] [Related]
7. Key Immunological Functions Involved in the Progression of Epithelial Ovarian Serous Carcinoma Discovered by the Gene Ontology-Based Immunofunctionome Analysis.
Chang CC; Su KM; Lu KH; Lin CK; Wang PH; Li HY; Wang ML; Lin CK; Yu MH; Chang CM
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30356023
[TBL] [Abstract][Full Text] [Related]
8. The Potential Role of Complement System in the Progression of Ovarian Clear Cell Carcinoma Inferred from the Gene Ontology-Based Immunofunctionome Analysis.
Su KM; Lin TW; Liu LC; Yang YP; Wang ML; Tsai PH; Wang PH; Yu MH; Chang CM; Chang CC
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316695
[TBL] [Abstract][Full Text] [Related]
9. Gene set-based integrative analysis of ovarian clear cell carcinoma.
Chang CM; Chiou SH; Yang MJ; Yen MS; Wang PH
Taiwan J Obstet Gynecol; 2016 Aug; 55(4):552-7. PubMed ID: 27590381
[TBL] [Abstract][Full Text] [Related]
10. Discovering the Deregulated Molecular Functions Involved in Malignant Transformation of Endometriosis to Endometriosis-Associated Ovarian Carcinoma Using a Data-Driven, Function-Based Analysis.
Chang CM; Yang YP; Chuang JH; Chuang CM; Lin TW; Wang PH; Yu MH; Chang CC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113136
[TBL] [Abstract][Full Text] [Related]
11. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
Vasconcelos I; Darb-Esfahani S; Sehouli J
BJOG; 2016 Mar; 123(4):498-508. PubMed ID: 26705090
[TBL] [Abstract][Full Text] [Related]
12. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis.
Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B
J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638
[TBL] [Abstract][Full Text] [Related]
13. Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States).
Cozen W; Peters R; Reichardt JK; Ng W; Felix JC; Wan P; Pike MC
Cancer Causes Control; 2002 Mar; 13(2):113-20. PubMed ID: 11936817
[TBL] [Abstract][Full Text] [Related]
14. Galactose-1 phosphate uridylyltransferase (GalT) gene: A novel positive regulator of the PI3K/Akt signaling pathway in mouse fibroblasts.
Balakrishnan B; Chen W; Tang M; Huang X; Cakici DD; Siddiqi A; Berry G; Lai K
Biochem Biophys Res Commun; 2016 Jan; 470(1):205-212. PubMed ID: 26773505
[TBL] [Abstract][Full Text] [Related]
15. Frequent microsatellite instability in epithelial borderline ovarian tumors.
Tangir J; Loughridge NS; Berkowitz RS; Muto MG; Bell DA; Welch WR; Mok SC
Cancer Res; 1996 Jun; 56(11):2501-5. PubMed ID: 8653685
[TBL] [Abstract][Full Text] [Related]
16. Biomolecular pathogenesis of borderline ovarian tumors: focusing target discovery through proteogenomics.
Vergara D; Tinelli A; Martignago R; Malvasi A; Chiuri VE; Leo G
Curr Cancer Drug Targets; 2010 Feb; 10(1):107-16. PubMed ID: 20088785
[TBL] [Abstract][Full Text] [Related]
17. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
[TBL] [Abstract][Full Text] [Related]
18. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors.
Ortiz BH; Ailawadi M; Colitti C; Muto MG; Deavers M; Silva EG; Berkowitz RS; Mok SC; Gershenson DM
Cancer Res; 2001 Oct; 61(19):7264-7. PubMed ID: 11585764
[TBL] [Abstract][Full Text] [Related]
19. Performance of the IOTA ADNEX Model on Selected Group of Patients with Borderline Ovarian Tumours.
Gaurilcikas A; Gedgaudaite M; Cizauskas A; Atstupenaite V; Paskauskas S; Gaurilcikiene D; Birzietis T; Vaitkiene D; Nadisauskiene RJ
Medicina (Kaunas); 2020 Dec; 56(12):. PubMed ID: 33322438
[No Abstract] [Full Text] [Related]
20. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
